Heavy metal induced oxidative stress & its possible reversal by chelation therapy

Indian Journal of Medical Research

Volumn 128, Issue 4, 2008, Pages 501-523

  Flora, S J S ^a   Mittal, Megha ^a   Mehta, Ashish ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Antioxidants supplementation; Apoptosis; Chelation therapy; Combination therapy; Heavy metal toxicity; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINOLEVULINIC ACID; ANTIOXIDANT; ARSENIC; ASCORBIC ACID; BETA CAROTENE; CADMIUM; DIMERCAPROL; EDETATE CALCIUM DISODIUM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE REGULATED PROTEIN 94; GLUTATHIONE; HEAT SHOCK PROTEIN 72; LEAD; MERCURY; METALLOTHIONEIN; MONOCYCLOHEXYL SUCCIMER; MONOISOAMYL SUCCIMER; MONOMETHYL SUCCIMER; NITRIC OXIDE; PORPHOBILINOGEN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUCCIMER; SUCCIMER DERIVATIVE; SUCCIMER MONOCYCLOHEXYL ESTER; SUPEROXIDE DISMUTASE; THIAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ANTIOXIDANT ACTIVITY; ANXIETY; APOPTOSIS; ARSENIC POISONING; BIOACCUMULATION; BIOSYNTHESIS; CADMIUM TOXICITY; CALCIUM EXCRETION; CARCINOGENICITY; CHELATION THERAPY; COMBINATION CHEMOTHERAPY; COMPLEX FORMATION; DNA DAMAGE; EXCRETION; HEADACHE; HEAVY METAL POISONING; HEMATURIA; HEME SYNTHESIS; HERBAL MEDICINE; HUMAN; IRON EXCRETION; LACRIMATION; LEAD POISONING; LIGAND BINDING; LIPID PEROXIDATION; METAL BINDING; MISMATCH REPAIR; NEPHROTOXICITY; NEUROTOXICITY; NITRIC OXIDE PRODUCTION; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; REVIEW; RHINORRHEA; SALIVATION; SIDE EFFECT; SIGNAL TRANSDUCTION; SWEATING; THORAX PAIN; UREA NITROGEN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; VOMITING; ZINC URINE LEVEL;

ANIMALS; CHELATING AGENTS; HUMANS; METALS, HEAVY; OXIDATIVE STRESS;

EID: 61849129297     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (223)

1. Leonard SS, Harris GK, Shi XL. Metal-induced oxidative stress and signal transduction. Free Rad Biol Med 2004; 37: 1921-42.
2. Chen F, Ding M, Castranova V, Shi XL. Carcinogenic metals and NF-kappa B activation. Mol Cell Biochem 2001; 222: 159-71.
3. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal-ions. Free Rad Biol Med 1995; 18: 321-36.
4. Florea AM, Busselberg D. Occurrence, use and potential toxic effects of metals and metal compounds. Biometals 2006; 19: 419-27.
5. Flora SJS, Flora G, Saxena G. Environmental occurrence, health effects and management of lead poisoning" In: Cascas SB, Sordo J, editors. Lead chemistry, analytical aspects, environmental impacts and health effects. Netherlands: Elsevier Publication; 2006. p. 158-228.
6. Goyer RA. Toxic effects of metals. In: Klaassen C, editor. Casarett & Doull's toxicology: The basic science of poisons. New York: McGraw-Hill; 1996. p. 691-737.
7. Ruff HA, Markowitz ME, Bijur PE, Rosen JF. Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. Environ Health Perspect 1996; 104: 180-5.
8. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res 1999; 24: 595-600.
9. Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10μg/dl in US children and adolescents. Public Health Rep 2000; 115: 521-9.
10. Khalil-Manesh F, Gonick HC, weiler EW, Prins B, Weber MA, Purdy RE. Lead-induced hypertension: possible role of endothelial factors. Am J Hypertens 1993; 6: 723-9.
11. Damek-Poprawa M, Sawicka-Kapusta K. Histopathological changes in the liver, kidneys, and testes of bank voles environmentally exposed to heavy metal emissions from the steelworks and zinc smelter in Poland. Environ Res 2004; 96: 72-8.
12. Sharma RP, Street JC. Public health aspects of toxic heavy metals in animal feeds. J Am Vet Med Assoc 1980; 177: 149-53.
13. Lancranjan I, Popscu HI, GA vanescu O, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 1975; 30: 396-401.
14. Ronis MJJ, Bedger TM, Shema SJ. Endocrine mechanism underlying the growth effects of developmental lead exposure in rat. J Toxicol Environ Health 1998; 54: 101-20.
15. Yiin SJ, Lin TH. Lead-catalyzed peroxidation of essential unsaturated fatty acid. Biol Trace Elem Res 1995; 50:167-72.
16. Bokara KK, Brown E, McCormick R, Yallapragada PR, Rajanna S, Bettaiya R Lead-induced increase in antioxidant enzymes and lipid peroxidation products in developing rat brain. Biometals 2008; 21: 9-16.
17. Adegbesan BO, Adenuga GA. Effect of lead exposure on liver lipid peroxidative and antioxidant defense systems of protein-undernourished rats. Biol Trace Elem Res 2007; 116: 219-25.
18. Saxena G, Flora SJS. Changes in brain biogenic amines and heme- biosynthesis and their response to combined administration of succimer and Centella asiatica in lead poisoned rats. J Pharm Pharmacol 2006; 58: 547-59.
19. Shafiq-ur-Rehman, Rehman S, Chandra O, Abdulla M. Evaluation of malondialdehyde as an index of lead damage in rat brain homogenates. Biometals 1995; 8: 275-9.
20. Adonaylo VN, Oteiza PI. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology 1999; 135: 77-85.
21. Sandhir R, Gill KD. Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem Res 1995; 48: 91-7.
22. Zhao Y, Wang L, Shen HB, Wang ZX, Wei QY, Chen F. Association between delta-aminolevulinic acid dehydratase (ALAD) polymorphism and blood lead levels: a meta-regression analysis. J Toxicol Environ Health A 2007; 70: 1986-94.
23. Saxena G, Joshi U, Flora SJS. Monoesters of meso 2, 3-dimercaptosuccinic acid in lead mobilization and recovery of lead induced tissue oxidative injury in rats. Toxicology 2005; 214: 39-56.
24. Chia SE, Yap E, Chia KS. Delta-aminolevulinic acid dehydratase (ALAD) polymorphism and susceptibility of workers exposed to inorganic lead and its effects on neurobehavioral functions. Neurotoxicology 2004; 25: 1041-7.
25. Guillermo O, Noriega, Maria L, Tomaro, Alcira MC. Bilirubin is highly effective in preventing in vivo δ-aminolevulinic acid-induced oxidative cell damage. Biochim Biophys Acta 2003; 1638: 173-8.
26. Flora SJS, Flora G, Saxena G, Mishra M. Arsenic and Lead Induced Free Radical Generation and Their Reversibility Following Chelation. Cell Mol Biol 2007; 53: 24-46.
27. Bechara EJH, Medeiros MHG, Monteiro HP, Hermes-Lima M, Pereira B, Demasi M, et al. A free radical hypothesis of lead poisoning and inborn porphyries associated with 5-aminolevulinic acid overload. Quim Nova 1996; 16: 385-92.
28. Ummus RE, Onuki J, Dornemann D, Marisa HG, Medeiros, Paolo DM. Measurement of 4,5-dioxovaleric acid by high-performance liquid chromatography and fluorescence detection. J Chromatogr B 1999; 729: 237-43.
29. Fuchs J, Weber S, Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Radical Biol Med 2000; 28: 537-48.
30. Blumerg A, Mart HR, Graber C. Parameters for the assessment of iron metabolism in chronic renal insufficiency. Contrib Nephrol 1984; 38: 135-40.
31. Flora SJS, Saxena G, Gautam P, Kaur P, Gill KD. Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSA. Chem-Biol Interact 2007; 170: 209-20.
32. Brennan PA, Kendrick KM, Keverne EB. Neurotransmitter release in the accessory olfactory bulb during and after the formation of an olfactory memory in mice. Neuroscience 1995; 69: 1075-86.
33. Lockitch G. Blood lead levels in children. CMAJ 1993; 149: 139-42.
34. Moreira EG, Vassilieff I, Vassilieff VS. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol 2001; 23: 489-95.
35. 2+". J Pharmacol Exp Ther 2007; 322: 108-16.
36. Xu J, Ji LD, Xu LH. Lead-induced apoptosis in PC 12 cells: Involvement of p53, Bcl-2 family and caspase-3. Toxicol Lett 2006; 166: 160-7.
37. Fox DA, He L, Poblenz AT, Carlos JM, Yvonne S, Srivastava D. Lead-induced alterations in retinal cGMP phosphodiesterase trigger calcium overload, mitochondrial dysfunction and rod photoreceptor apoptosis. Toxicol Lett 1998; 102-103: 359-61.
38. Hsu JM. Lead toxicity related to glutathione metabolism. J Nutr 1981; 111: 26-33.
39. Ito Y, Niiya Y, Kurita H, Shima S, Sarai S. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int Arch Occup Environ Health 1985; 56: 119-27.
40. Sugawara E, Nakamura K, Miyake T, Fukumura A, Seki Y. Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br J Ind Med 1991; 48: 239-42.
41. Chiba M, Shinohara A, Matsushita K, Watanabe H, Inaba Y. Indices of lead exposure in blood and urine of lead exposed workers and concentration of major and trace element and activities of SOD, GSH-Px and catalase in their blood. Tohoku J Exp Med 1996; 178: 49-62.
42. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radical Biol Med 2000; 29: 927-45.
43. Gurer H, Ozgunes H, Neal R, Spitz DR, Ercal N. Antioxidant effects of N-acetyl cysteine and succimer in red blood cells from lead exposed rats. Toxicology 1998; 128: 181-9.
44. Cocco P. Occupational lead exposure and screening of glucose-6-phosphate dehydrogenase polymorphism: useful prevention or nonvoluntary discrimination? Int Arch Occup Environ Health 1998; 71: 148-50.
45. Valle BL, Ulmer DD. Biochemical effects of mercury, cadmium and lead. Annu Rev Biochem 1972; 41: 91-128.
46. Lachant NA, Tomoda A, Tanaka KR. Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood 1984; 63: 518-24.
47. Cocco P, Salis S, Anni M, Cocco ME, Flore C, Ibba A. Effects of short term occupational exposure to lead on erythrocyte glucose 6- phosphate dehydrogenase activity and serum cholesterol. J Appl Toxicol 1995; 15: 375-8.
48. Gelman BB, Michaelson IA., Bus JS. The effect of lead on oxidative hemolysis and erythrocyte defense mechanisms in the rat. Toxicol Appl Pharmacol 1978; 45: 119-29.
49. Howard JK. Human erythrocyte glutathione reductase and glucose 6-phosphate dehydrogenase activities in normal subjects and in persons exposed to lead. Clin Sci Mol Med 1974; 47: 515-20.
50. Rausa G. Behavior of erythrocyte glucose 6- phosphate dehydrogenase in rats treated subcutaneously with lead acetate. Chem Abstr 1969; 71: 125.
51. Calderon-Salinas V, Hernandez Luna C, Maldonado MV, Sáenz DR. Mechanism of the toxic effects of lead. I. Free lead in erythrocyte. J Expo Anal Environ Epidemiol 1993; 3: 153-64.
52. Rogers LE, Battles ND, Reimold EW, Sartain P. Erythrocyte enzymes in experimental lead poisoning. Arch Toxicol 1971; 28: 202-7.
53. Wang J, Wu J, Zhang Z. Oxidative stress in mouse brain exposed to lead. Ann Occup Hyg 2006; 50: 405-9.
54. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 263: 17205-8.
55. Mehta A, Flora G, Dube S, Flora SJS. Succimer and its analogues: Antidotes for metal poisoning. In: Flora SJS, Romano JA, editors. Pharmacological perspectives of some toxic chemicals and antidotes. New Delhi: Narosa Publication; 2004. p. 445-66.
56. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 1995; 251: 8-28.
57. Thomas JA, Poland B, Honzatko R. Protein sulfhydryl and their role in the antioxidant function of protein thiolation. Arch Biochem Biophys 1995; 319: 1-9.
58. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev 1998; 3: 262-70.
59. Whanger PD. Selenium in the treatment of heavy metals poisoning and chemical carcinogenesis. J Trace Elem Elect 1992; 6: 209-21.
60. Mylroie AA, Umbles C, Kyle J. Effects of dietary copper supplementation on erythrocyte superoxide dismutase activity, ceruloplasmin and related parameters in rats ingesting lead acetate. In: Hemphill, editor. Trace substances in environ health. Columbia: University of Missouri Press; 1984; 18: 497-504.
61. Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine. 2nd ed. Oxford: Clarendon Press; 1989.
62. Evans CD, LaDow K, Schumann BL, Savage RE, Caruso J, Vonderheide A, et al. Effect of arsenic on benzo[a] pyrene DNA adduct levels in mouse skin and lung. Carcinogenesis 2004; 25: 493-7.
63. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161-208.
64. Waalkes MP, Liu J, Ward JM, Diwan BA. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 2004; 198: 31-8.
65. Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC. Induction of gene amplification by arsenic. Science 1988; 241: 79-81.
66. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora SJS. Arsenic induced changes in certain neurotransmitters levels and their recoveries following chelation in rat whole brain. Toxicol Lett 1997; 92: 201-8.
67. Puccetti E, Ruthardt M. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell. Leukemia 2004; 18: 1169-75.
68. Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 2004; 255: 67-78.
69. Pi J, Horiguchi S, Sun Y, Nikaido M, Shimojo N, Hayashi T, et al. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radical Biol Med 2003; 35: 102-13.
70. Rin K, Kawaguchi K, Yamanaka K, Tezuka M, Oku N, Okada S.DNA-strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicals. Biol Pharm Bull 1995; 18: 45-8.
71. Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S. Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2′-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem Biophys Res Commun 2001; 287: 66-70.
72. Iwama K, Nakajo S, Aiuchi T. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer 2001; 92: 518-26.
73. Kessel M, Lin SX, Santella R, Hei TK. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem 2002; 234-235: 301-8.
74. Lynn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 2000; 86: 514-9.
75. Huang HS, Chang WC, Chen CJ. Involvement of reactive oxygen species in arsenite-induced downregulation of phospholipid hydroperoxide glutathione peroxidase in human epidermoid carcinoma A431 cells. Free Radical Biol Med 2002; 33: 864-73.
76. Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radical Biol Med 1999; 27: 1405-12.
77. Trouba KJ, Geisenhoffer KM, Germolec DR. Sodium arsenite-induced stress-related gene expression in normal human epidermal, HaCaT, and HEL30 keratinocytes. Environ Health Perspect 2002; 110: 761-6.
78. Ma DC, Sun YH, Chang KZ, Ma XF, Huang SL, Bai YH, et al. Selective induction of apoptosis of NB4 cells from G2+M phase by sodium arsenite at lower doses. Eur J Haematol 1998; 61: 27-35.
79. Cantoni O, Hussain S, Guidarelli A, Cattabeni F. Cross-resistance to heavy metals in hydrogen peroxide-resistant CHO cell variants. Mutat Res 1994; 324: 1-6.
80. Bongiovanni GA, Soria FA, Eynard AR. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food Chem Toxicol 2007; 45: 971-6.
81. Corsini E, Asti L, Viviani B, Marinovich M, Galli CL Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: role of mitochondria. J Invest Dermatol 1999; 113: 760-5.
82. Samikkannu T, Chen CH, Yih LH, Wang AS, Lin SY, Chen TC, et al. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem Res Toxicol 2003; 16: 409-14.
83. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 2007; 220: 146-55.
84. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002; 133: 1-16.
85. Aposhian HV, Aposhian MM. Arsenic Toxicology: Five Questions. Chem Res Toxicol 2006; 19: 1-60.
86. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 1995; 91: 2306-9.
87. Geller RDA. Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 1996; 24: 1238-45.
88. Mordan LJ, Burnett TS, Zhang LX, Tom J, Cooney RV. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 1993; 14: 1555-9.
89. Dong Z. The Molecular Mechanisms of Arsenic-Induced Cell Transformation and Apoptosis. Environ Health Perspect 2002; 110: 757-9.
90. Balakumar P, Kaur T, Singh M. Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions. Toxicology 2007 (in press).
91. Son MH, Kang KW, Lee CH, Kim SG. Potentiation of arsenic-induced cytotoxicity by sulfur amino acid deprivation (SAAD) through activation of ERK1/2, p38 kinase and JNK1: the distinct role of JNK1 in SAAD-potentiated mercury toxicity. Toxicol Lett 2001; 121: 45-55.
92. Namgung UK, Xia Z. Arsenic Induces Apoptosis in Rat Cerebellar Neurons via Activation of JNK3 and p38 MAP Kinases. Toxicol Appl Pharmacol 2001; 174: 130-8.
93. Wu MM, Chiou HY, Hsueh YM, Hong CT, Su CL, Chang SF, et al. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol Appl Pharmacol 2006; 216: 168-75.
94. Kannan GM, Flora SJS. Chronic arsenic poisoning in the rat: treatment with combined administration of succimers and an antioxidant. Ecotoxicol Environ Safety 2004; 58: 37-43.
95. Mishra D, Mehta A, Flora SJS. Reversal of hepatic apoptosis with combined administration of DMSA and its analogues in guinea pigs: Role of glutathione and linked enzymes. Chem Res Toxicol 2008; 21: 400-7.
96. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol 1996; 169: 256-68.
97. Karin M, Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA 1998; 95: 9067-9.
98. Hu Y, Jin X, Snow ET. Effect of arsenic on transcription factor AP-1 and NF-κB DNA binding activity and related gene expression. Toxicol Lett 2002; 133: 33-45.
99. Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton JW. Differential effects of arsenic (III) and chromium (VI) on nuclear transcription factor binding. Mol Carcinog 1999; 25: 219-29.
100. Arnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-70.
101. Pulido MD, Parrish AR. Metal-induced apoptosis: mechanisms. Mutat Res 2003; 533: 227-41.
102. Jingbo Pi, Wei Qu, Jeffrey M. Reece, Yoshito Kumagai, Michael P. Waalkes. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res 2003; 290: 234-45.
103. Sumia D, Manjib A, Shinkaia Y, Toyamab T, Kumagai Y. Activation of the Nrf2 pathway, but decreased γ-glutamylcysteine synthetase heavy subunit chain levels and caspase-3-dependent apoptosis during exposure of primary mouse hepatocytes to diphenylarsinic acid. Toxicol Appl Pharmacol 2007; 223: 218-24.
104. Casalino E, Calzaretti G, Landriscina M, Sblano C, Fabiano A, Landriscina C. The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: Comparison with the toxic effect on NAD(P)H: quinonereductase. Toxicology 2007; 237: 24-34.
105. Hideaki S, Yasutake A, Hirashima T, Takamure Y, Kitano T, Waalkes MP, et al. Strain difference of cadmium accumulation by liver slices of inbred Wistar-Imamichi and Fischer 344 rats. Toxicology In Vitro 2008; 22: 338-43.
106. IARC, International Agency for Research on Cancer, Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. In: International agency for research on cancer monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Scientific Publications; 1993; 58: 119-237.
107. Galan C, Garcia BL, Troyano A, Vilaboa NE, Fernandez C, Blas DE, et al. The role of intracellular oxidation in death induction (apoptosis and necrosis) in human promonocytic cells treated with stress inducers (cadmium, heat, X-rays). Eur J Cell Biol 2001; 80: 312-20.
108. Watanabe M, Henmi K, Ogawa K, Suzuki T. Cadmium-dependent generation of reactive oxygen species and mitochondrial DNA breaks in photosynthetic and non-photosynthetic strains of Euglena gracilis. Comp Biochem Physiol C Toxicol Pharmacol 2003; 134: 227-34.
109. Casalino E, Sblano C, Landriscina C. Enzyme activity alteration by cadmium administration to rats: the possibility of iron involvement in lipid peroxidation. Arch Biochem Biophys 1997; 346: 171-9.
110. Waisberg M, Joseph P, Hale B, Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 2003; 192: 95-117
111. Watjen W, Beyersmann D. Cadmium-induced apoptosis in C6 glioma cells: influence of oxidative stress. Biometals 2004; 17: 65-78.
112. Casalino E, Calzaretti G, Sblano C, Landriscina C. Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. Toxicology 2002; 30: 37-50.
113. Yang JM, Arnush M, Chen QY, Wu XD, Pang B, Jiang XZ. Cadmium-induced damage to primary cultures of rat Leydig cells. Reprod Toxicol 2003; 17: 553-60.
114. Cosic DD, Bulat ZP, Ninkovic M, Malicevic Z, Matovic V. Effect of subacute cadmium intoxication on iron and lipid peroxidation in mouse liver. Toxicol Lett 2007; 172: S209.
115. Ognjanovic BI, Pavlovic SZ, Maletic SD, Zikic RV, Stajn AS, Radojicic RM, et al. Protective influence of vitamin E on antioxidant defense system in the blood of rats treated with cadmium. Physiol Res 2003; 52: 563-70.
116. McMurray CT, Tainer JA. Cancer, cadmium and genome integrity. Nat Genet 2003; 34: 239-41.
117. Jin YH, Clark AB, Slebos RJ, Al-Refai H, Taylor JA, Kunkel TA, et al. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat Genet 2003; 34: 326-9.
118. Beytut E, Yuce A, Kamiloglu NN, Aksakal M. Role of dietary vitamin E in cadmium-induced oxidative damage in rabbit's blood, liver and kidneys. Int J Vitam Nutr Res 2003; 73: 351-5.
119. Cosic DD, Bulat ZP, Ninkovic M, Malicevic Z, Matovic V. Effect of subacute cadmium intoxication on iron and lipid peroxidation in mouse liver. Toxicol Lett 2007; 72: S209.
120. Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001; 292: 2083-6.
121. Karbownik M, Gitto E, Lewinski A, Reiter RJ. Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: melioration by melatonin. Cell Biol Toxicol 2001; 17: 33-40.
122. Fitzgerald WF, Clarkson TW. Mercury and monomethylmercury: present and future concerns Environ Health Perspect 1991; 96: 159-66.
123. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev 2000; 52: 113-43.
124. Hultberg B, Anderson A, Isaksson A. Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology 2001; 156: 93-100.
125. McGoldrick TA, Lock EA, Rodilla V, Hawksworth GM. Renal cysteine conjugate C-S lyase mediated toxicity of halogenated alkenes in primary cultures of human and rat proximal tubular cells. Arch Toxicol 2003; 77: 365-70.
126. Houser MT, Berndt WO. Unilateral nephrectomy in the rat: effects on mercury handling and renal cortical subcellular distribution. Toxicol Appl Pharmacol 1988; 93: 187-94.
127. Baggett JM, Berndt WO. The effect of potassium dichromate and mercuric chloride on urinary excretion and organ and subcellular distribution of [203Hg] mercuric chloride in rats. Toxicol Lett 1985; 29: 115-21.
128. Madsen KM, Hansen JC. Subcellular distribution of mercury in the rat kidney cortex after exposure to mercuric chloride. Toxicol Appl Pharmacol 1980; 54: 443-53.
129. Zalups RK, Barfuss DW. Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J Am Soc Nephrol 1998; 9: 551-61.
130. Zalups RK. Intestinal handling of mercury in the rat: implications of intestinal secretion of inorganic mercury following biliary ligation or cannulation. J Toxicol Environ Health A 1998; 53: 615-36.
131. Yoshida M, Watanabe C, Kishimoto M, Yasutake A, Satoh M, Sawada M, Akama Y. Behavioral changes in metallothioneinnull mice after the cessation of long-term, low-level exposure to mercury vapor. Toxicol Lett 2006; 161: 210-8.
132. Zalups RK, Cherian MG. Renal metallothionein metabolism after a reduction of renal mass. I. Effect of unilateral nephrectomy and compensatory renal growth on basal and metal-induced renal metallothionein metabolism. Toxicology 1992; 71: 83-102.
133. Cherian MG, Clarkson TW. Biochemical changes in rat kidney on exposure to elemental mercury vapor: effect on biosynthesis of metallothionein. Chem Biol Interact 1976; 12: 109-20.
134. 2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 1993; 45: 2017-24.
135. 2 production and lipid peroxidation in vitro in rat kidney mitochondria. Biochem Pharmacol 1991; 42: S181-7.
136. Mahboob M, Shireen KF, Atkinson A, Khan AT. Lipid peroxidation and antioxidant enzyme activity in different organs of mice exposed to low level of mercury. J Environ Sci Health B 2001; 36: 687-97.
137. Yee S, Choi BH. Oxidative stress in neurotoxic effects of methyl mercury poisoning. Neurotoxicology 1996; 17: 17-26.
138. Papaconstantinou AD, Brown KM, Noren BT, McAlister T, Fisher BR, Goering PLV Mercury, cadmium, and arsenite enhance heat shock protein synthesis in chick embryos prior to embryo toxicity. Birth Defect Res B Dev Reprod Toxicol 2003; 68: 456-64.
139. Goering PL, Fisher BR, Noren BT, Papaconstantinou A, Rojko JL, Marler RJ. Mercury induces regional and cell-specific stress protein expression in rat kidney. Toxicol Sci 2000; 53: 447-57.
140. Kety SS, Letonoff TV. Treatment of lead poisoning with sodium citrate. Proc Soc Exp Biol Med 1941; 46: 276.
141. Andersen O. Principles and recent developments in chelation treatment of metal intoxication. Chem Rev1999; 99: 2683-710.
142. Carleton AB, Peters RA, Stocken LA, Thompson RH, Williams DI, Storey ID, et al. Clinical uses of 2,3-dimercaptopropanol (bal). Vi. The treatment of complications of arseno-therapy with BAL (British Anti-lewisite). J Clin Invest 1946; 25: 497-527.
143. Hoover TD, Aposhian HV. BAL increases the arsenic-74 content of rabbit brain. Toxicol Appl Pharmacol 1983; 70: 160-2.
144. Klaassen CD. Goodman and Gilman's. The pharmacological basis of therapeutics. USA: Pergamon Press; 1990. p. 1592-614.
145. Flora SJS, Bhattacharya R, Vijayaraghavan R. Combined therapeutic potential of Meso 2, 3 dimercaptosuccinic acid and calcium disodium edetate in experimental lead Intoxication in rats. Fundam Appl Toxicol 1995; 25: 233-40.
146. Cory-Slechta DA, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylene diamine tetra acetate chelation therapy. J Pharmacol Exp Ther 1987; 243: 804-13.
147. Flora SJS, Pant BP, Tripathi N, Kannan GM, Jaiswal DK. Distribution of arsenic by diesters of Meso 2, 3-dimercaptosuccinic acid during sub-chronic intoxication in rats. J Occup Health 1997; 39: 119-23.
148. Gubrelay U, Mathur R, Flora SJS. Treatment of arsenic poisoning: an update. Ind J Pharmacol 1998; 30: 209-17.
149. Guha Mazumder DN, Das Gupta J, Santra A. Chronic arsenic toxicity in West Bengal-The worst calamity in the world. J Indian Med Assoc 1998; 96: 4-7.
150. Zhang J, Wang XF, Lu ZB, Liu NO, Zhao BL. The effects of meso-2,3-dimercaptosuccinic acid and oligomeric procyanidins on acute lead neurotoxicity in rat hippocampus. Free Radical Biol Med 2004; 37: 1037-50.
151. Walker EM, Stone A, Milligan LB, Gale GR, Atkins LM, Smith AB, et al. Mobilization of lead in mice by administration of monoalkyl esters of meso 2, 3-dimercaptosuccinic acid. Toxicology 1992; 76: 79-87.
152. Flora SJS, Dubey R, Kannan GM, Chauhan RS, Pant BP, Jaiswal DK. meso 2, 3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicol Lett 2002; 132: 9-17.
153. Flora SJS, Mehta A, Rao PVL, Kannan GM, Bhaskar ASB, Dube SN, et al. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rat. Toxicology 2004; 195: 127-46.
154. Mehta A, Flora SJS. Possible Role of metal redistribution, hepatotoxicity and oxidative stress in chelating agents induced hepatic and renal metallothionein in rats. Food Chem Toxicol 2001; 39: 1029-38.
155. Mehta A, Pant SC, Flora SJS. Monoisoamyl dimercaptosuccinic acid induced changes in pregnant female rats during late gestation and lactation. Reproduct Toxicol 2006; 21: 94-103.
156. Jones MM, Singh PK, Gale GR, Smith AB, Atkins LM. Cadmium mobilization in vivo by intraperitoneal or oral administration of mono alkyl esters of meso 2, 3-dimercaptosuccinic acid. Pharmacol Toxicol 1992; 70: 336-43.
157. Flora SJS, Nutritional Components Modify Metal Absorption, Toxic Response and Chelation therapy. J Nutr Environ Med 2002; 12: 51-65.
158. Ramanathan K, Anusuyadevi M, Shila S, Panneerselvam C. Ascorbic acid and tocopherol as potent modulators of apoptosis on arsenic induced toxicity in rats. Toxicol Lett 2005; 156: 297-306.
159. Young IS, Woodside IS. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-86.
160. Rendon-Ramirez A, Cerbon-Solorzano J, Maldonado-Vega M, Quintanar-Escorza MA, Calderon-Salinas JV. Vitamin-E reduces the oxidative damage on a-aminolevulinic dehydratase induced by lead intoxication in rat erythrocytes. Toxicology In Vitro 2007; 21: 1121-6.
161. Mishra M, Acharya UA. Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice. J Trace Elem Med Biol 2004; 18: 173-8.
162. Flora SJS, Tandon SK. Preventive and therapeutic effects of thiamine, ascorbic acid and their combination in lead intoxication. Acta Pharmacol Toxicol 1986; 58: 374-8.
163. Goyer RA, Cherian MG. Ascorbic acid and EDTA treatment of lead toxicity in rats. Life Sci 1979; 24: 433-8.
164. Simon JA, Hudes ES. Relationships of ascorbic acid to blood lead levels. JAMA 1999; 281: 2289-93.
165. Dawson EB, Harris WA. Effect of ascorbic acid supplementation on blood lead levels. J Am Coll Nutr 1997; 16: 480.
166. Patra RC, Swarup D, Dwivedi SK. Antioxidant effects of a-tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 2001; 162: 81-8.
167. Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 1998; 141: 249-57.
168. Demerdash FM, Yousef MI, Kedwany FS, Baghdadi HH. Cadmium induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and β -carotene. Food Chem Toxicol 2004; 42: 1563-71.
169. Prescott LF. Paracetamol over dosage: pharmacological considerations and clinical management. Drugs 1983; 25: 290-314.
170. Bray GP, Treger JH, Williams R. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology 1992; 15: 297-301.
171. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 2007; 220: 146-55.
172. Zahir A, Shaikh, Khalequz Zaman, Weifeng Tang and Thanhtam Vu. Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine. Toxicol Lett 1999; 104: 137-42.
173. Pande M, Mehta A, Pant BP, Flora SJS. Combined administration of a chelating agent and an antioxidant in the prevention and treatment of acute lead intoxication in rats. Environ Toxicol Pharmacol 2001; 9: 173-84.
174. Flora SJS. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2, 3- dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol 1999; 26: 865-9.
175. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Lipoic acid in liver metabolism and disease. Free Radical Biol Med 1998; 24: 1023-39.
176. Pande M, Flora SJS. Lead induced oxidative damage and its response to combined administration of α-Lipoic acid and succimers in rats. Toxicology 2002; 177: 187-96.
177. Sumathi R, Baskaran G, Varalakshmi P. Effect of DL α-lipoic acid on tissue redox state in acute cadmium challenged tissues. J Nut Biochem 1996; 7: 85-92.
178. Müller L. Protective effects of DL-α-lipoic acid on cadmium-induced deterioration of rat hepatocytes. Toxicology 1989; 58: 175-85.
179. Garcia JJ, Reiter RJ, Guerrero JM, Escamer G, Yu BP, Oh CS, et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408: 297-300.
180. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin, a peroxide radical scavenger more effective than vitamin E. Life Sci 1994; 55: 271-6.
181. Tan DX, Chen LD, Poeggler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
182. Flora SJS, Pande M, Kannan GM, Ashish Mehta. Lead induced Oxidative Stress and its Recovery following Co-administration of Melatonin or N- acetylcysteine during Chelation with Succimer in Male Rats. Cell Mol Biol 2004; 50: OL543-51.
183. Melatonin protects against copper-mediated free radical damage. J Pineal Res 2002; 32: 237-42.
184. Karbownik M, Gitto E, Lewinski A, Reiter RJ. Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin. Cell Biol Toxicol 2001; 17: 33-40.
185. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 2004; 98: 266-75.
186. Pal S, Chatterjee AK. Possible Beneficial Effects of Melatonin Supplementation on Arsenic-Induced Oxidative Stress in Wistar Rats. Drug Chem Toxicol 2006; 29: 423-33.
187. Melchiorri RJ, Reiter AM, Atlia M, Hara A, Burgos, Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56: 83-9.
188. Kim YO, Pyo MY, Kim JH. Influence of melatonin on immunotoxicity of lead. Int J Immunopharmacol 2000; 22: 821-32.
189. Othman AI, Sharawy S. Al, Missiry M. A. El. Role of melatonin in ameliorating lead induced haematotoxicity. Pharmacol Res 2004; 50: 301-7.
190. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000; 9: 160-71.
191. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001; 426: 1-10.
192. Gamal H El-Sokkary, Gamal H Abdel Rahman, Esam S Kamel. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005; 213: 25-33.
193. Mayo JC, Tan DX, Sainz RM, Natarajan M, Lopez Burillo S, Reiter RJ. Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. Biochim Biophys Acta 2003; 1620: 139-50.
194. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metabol 2003; 2: 273-85.
195. Kotler M, Rodriguez C, Sainz RM, Antolin I, Menendez Pelaez A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24: 83-9.
196. Reiter RJ, Tan DX, Cabrera J, Aropa DD, Sainz RM, Mayo JC, et al. The oxidant/antioxidant network: role of melatonin, Biol Signals Recept 1999; 8: 56-63.
197. Garcia JJ, Reiter RJ, Guerrero JM, Escamer G, Yu BP, Oh CS, et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408: 297-300.
198. Chwelatiuk E, Wlostowski T, Krasowska A, Bonda E. The effect of orally administered melatonin on tissue accumulation and toxicity of cadmium in mice. J Trace Elem Med Biol 2006; 19: 259-65.
199. Cano P, Ariel HB, Poliandri, Vanessa Jiménez, Daniel P, Cardinali Ana I, et al. Cadmium-induced changes in Per 1 and Per 2 gene expression in rat hypothalamus and anterior pituitary: Effect of melatonin. Toxicol Lett 2007; 172: 131-6.
200. Kostial K, Dekanic D, Telisman S, Blanuska M, Duvanaic S, Prpic-Majic D, et al. Dietary calcium and blood levels in women. Biol Trace Elem Res 1991; 28: 181-5.
201. Flora SJS. Influence of simultaneous supplementation of zinc and copper during chelation of lead in rats. Hum Exp Toxicol 1991; 10: 331-6.
202. Bhadauria S, Flora SJS. Response of arsenic induced oxidative stress, DNA damage and metal imbalance to combined administration of DMSA and monoisoamyl DMSA during chronic arsenic poisoning in rats. Cell Biol Toxicol 2007; 23: 91-104.
203. Flora SJS, Singh S, Tandon SK. Chelation in Metal Intoxication XVIII: Combined effects of thiamine and calcium disodium versenate on lead toxicity. Life Sci 1986; 38: 67-71.
204. Flora SJS, Tandon SK. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats. Toxicology 1990; 64: 129-39.
205. Flora SJS, Pant SC, Sachan AS. Mobilisation and distribution of lead over the course of combined treatment with thiamin and meso 2, 3-dimercaptosuccinic acid or 2, 3-dimercapto propane 1-sulfonate in experimental lead intoxication in rats. Clin Chem Enzymol Comm 1994; 6: 207-16.
206. Tandon SK, Singh S, Flora SJS. Influence of methionine-zinc supplementation during chelation of lead in rats. J Trace Elem Electrol Health Dis 1994; 8: 75-8.
207. Mishra D, Flora SJS. Quercetin administration during chelation therapy protects arsenic induced oxidative stress in mouse. Biol Trace Element Res 2008 (in press).
208. Lauwerys R, Roels H, Buchet JP. The influence of orally administered vitamin C or zinc on the absorption of and the biological response to lead. J Occup Med 1983; 25: 668-78.
209. Kannan GM, Flora SJS. Chronic Arsenic Poisoning in Rat: Treatment with Combined Administration of Succimers and an Antioxidant. Ecotoxicol Environ Saf 2004; 58: 37-43.
210. Modi M, Flora SJS. Combined administration of iron and monoisoamyl DMSA in the treatment of chronic arsenic intoxication in mice. Cell Biol Toxicol 2007: 23: 429-43.
211. Geetha S, Sai Ram M, Singh V, Ilavazhagan G, Sawhney RC. Antioxidant and immunomodulatory properties of Sea buckthorn (Hippophae rhamnoides L.): an in vitro study. J Ethnopharmacol 2002; 79: 373-8.
212. Gupta R, Dubey DK, Kannan GM, Flora SJS. Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic induced oxidative stress in mouse. Cell Biol Int 2007; 31: 44-56
213. Gupta R, Flora SJS. Protective effects of fruit extracts of Hippophae rhamnoides against arsenic toxicity in swiss albino mice. Human Exp Toxicol 2006; 25: 285-95.
214. Gupta R, Flora SJS. Effect of Centella asiatica on arsenic induced oxidative stress and metal distribution in rats. J Appl Toxicol 2006; 26: 213-22.
215. Mishra D, Gupta R, Pant SC, Kushwah P, Satish HT, Flora SJS. Therapeutic potential of combined administration of MiADMSA and Moringa oleifera seed powder on arsenic induced oxidative stress and metal distribution in mouse. Toxicol Mechanism Methods 2008 (in press).
216. Grindlay G, Reynolds T. The Aloe vera phenomenon A review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol 1980; l16: 117-51.
217. Flora SJS, Pande M, Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 2003; 145: 267-80.
218. Flora SJS, Bhadauria S, Kannan GM, Singh N. Arsenic induced oxidative stress and role of antioxidant supplementation during chelation: A Review. J Environ Biol 2007; 28: 333-47.
219. Kalia K, Flora SJS. Strategies for Safe and Effective Treatment for Chronic Arsenic and Lead Poisoning. J Occup Health 2007; 47: 1-21.
220. Flora GJS, Seth PK, Flora SJS. Recoveries in lead induced alteration in rat brain biogenic amines levels following combined chelation therapy with meso 2, 3-dimercaptosuccinic acid and calcium disodium versenate. Biogenic Amines 1997; 13: 79-90.
221. Mittal M, Flora SJS. Effects of individual and combined exposure to sodium arsenite and sodium fluoride on tissue oxidative stress, arsenic and fluoride levels in male mice. Chem Biol Interact 2006; 162: 128-39.
222. Chouhan S, Flora SJS. Effects of fluoride on the tissue oxidative stress and apoptosis in rats: biochemical assays supported by IR spectroscopy data. Toxicology 2008 (in press).
223. Flora SJS, Mehta A, Gupta R. Prevention of arsenic induced hepatic apoptosis by concomitant administration of garlic extracts in mice. Chem Biol Interact 2008 (in press).